Lv11
45 积分 2021-08-02 加入
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors
2小时前
待确认
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
12天前
已完结
Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference
1个月前
已完结
影响再次肾移植临床效果的主要因素
1个月前
已完结
Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts
1个月前
已完结
Impact of CYP3A4*22 Allele on Tacrolimus Pharmacokinetics in Early Period After Renal Transplantation Toward Updated Genotype-Based Dosage Guidelines
1个月前
已完结
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
2个月前
已完结
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen
2个月前
已完结
Conversion of Stable Kidney Transplant Recipients From a Twice Daily Prograf-Based Regimen to a Once Daily Modified Release Tacrolimus-Based Regimen
2个月前
已完结
Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen
2个月前
已完结
皖公网安备34019202002308
